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Dear Editor,
Five-aminolevulinic acid-induced tumor fluorescence is re-
ceiving increasing attention as a surgical tool after the first
reports describing its use in high grade gliomas 1998 [10–13].
Approval in the European Union was based on a consecutive
phase III trial in 322 patients which showed a higher rate of
complete resections and 6-month progression-free survival in
patients operated on using 5-ALA [11]. Meningiomas, benign
as well as atypical subtypes, have also been observed to
accumulate fluorescence in response to 5-ALA [1–7]. Specif-
ically, Coluccia et al. showed 5-ALA to induce porphyrin
fluorescence in 31 of 33 patients with meningiomas (32 of
them WHO I-II, one WHO III) [2]. Even for grade I menin-
giomas of the sphenoid bone, accumulation of protoporphyrin
IX (PpIX) fluorescence has been described. Quantitative de-
tection of protoporphyrin IX concentrations using spectrogra-
phy allowed more accurate detection of the extent of tissue
infiltration by meningioma cells in the case of a 52-year-old
patient [1]. Kajimoto et al. reported on the usefulness of 5-
ALA-induced fluorescence for the detection of residual cells
of atypical meningiomas in the dura [6], and the use of 5-ALA
for the resection of grade II meningiomas with osseus infiltra-
tion has been pointed out as well [8]. Hefti et al. compared the
accumulation of PpIX in two human meningioma cell lines
(HBL-52 and BEN-MEN-I) and observed PpIX concentra-
tions increased to up to five times normal level in BEN-MEN-
1 cells (while the ferrochelatase activity was 2.7 times higher
in HBL-52 cells), with a much higher sensitivity to photody-
namic therapy (PDT) [4]. PDT relies on the interaction of laser
light and porphyrin IX, which, apart from its fluorescence, is
also a potent photosensitizer.
Atypical meningiomas have a high recurrence rate of 41 %
in five years [5], possibly because the true extent of infiltration
of adjacent tissue is not distinguishable, and residual tumor is
missed surgically.
With this letter we would like to share our experi-
ence regarding a 21-year-old young female patient with
atypical meningioma in whom brain dura and brain
infiltration could be well visualized using 5-ALA. This
patient presented with recurrent right-sided, parasagittal,
postcentral atypical meningioma (WHO grade II) initial-
ly resected five years earlier and adjuvantly treated by
radiosurgery (18 Gy). Resection was performed using 5-
ALA (Gliolan®, 20 mg/kg). Fluorescence was noted in
the gross tumor. However, several small areas of distinct
fluorescence were also observed within the adjacent
dura and, importantly, also in the arachnoid of the
adjacent cortex. Histological examination revealed
meningothelial tumor cells in both the cortex and the
brain (Fig. 1).
Thus, 5-ALA (Gliolan®)-derived tumor fluorescence
appeared useful for detecting these areas of residual
infiltration in the dura but more importantly, also in
the adjacent brain, which could be the origin of further
recurrences; this has not previously been reported. This
observation points out that the adjacent arachnoid may
in fact be the source of some tumor recurrences despite
macroscopically complete resections of gross tumor and
the adjacent dura. Infiltrative growth of meningiomas
has been identified as an important factor driving
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prognosis in patients even with grade I meningiomas
[9], and gross total resection of malignant meningio-
mas has been associated with improved survival. Thus,
5-ALA-derived tumor fluorescence may help in improv-
ing the prognosis in patients with invasive but otherwise
benign meningiomas, as well as in patients with atypical
or anaplastic meningiomas. The detection of PpIX in the
infiltrating tumor may also provide a rationale for adju-
vant PDT in these lesions.
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Fig. 1 Left: Red fluorescent atypical meningioma after 5-ALA with
fluorescence in tumor, adjacent dura and arachnoid overlying cortex.
Right: Corresponding white light image. Center: Elastica-van-Gieson
staining of biopsies. Top: Adjacent, fluorescing dura (“d”); middle: gross
tumor and bottom: invaded brain (“c”: cortex)
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